ISSN 1662-4009 (online)

ey0015.12-16 | New Concerns | ESPEYB15

12.16 Lipid Profiles, Inflammatory Markers, and Insulin Therapy in Youth with Type 2 Diabetes

LE Levitt Katz , F Bacha , SS Gidding , RS Weinstock , L El Ghormli , I Libman , KJ Nadeau , K Porter , S Marcovina , TODAY Study Group

To read the full abstract: J Pediatr 2018;196:208-216.e2Insulin deficiency or resistance activates intracellular hormone-sensitive lipase; this increases the release of non-esterified fatty acids from triglycerides stored in centrally distributed adipose tissue. High circulating levels of non-esterified fatty acids increase hepatic triglyceride synthesis, which in turn increases secretion o...

ey0016.12-5 | Type 2 Diabetes | ESPEYB16

12.5. Liraglutide in children and adolescents with type 2 diabetes

WV Tamborlane , M Barrientos-Perez , U Fainberg , H Frimer-Larsen , M Hafez , PM Hale , MY Jalaludin , M Kovarenko , I Libman , JL Lynch , P Rao , N Shehadeh , S Turan , D Weghuber , T Barrett , I Ellipse Trial

N Engl J Med 2019; 10.1056/NEJMoa1903822.DOI: 10.1056/NEJMoa1903822http://www.ncbi.nlm.nih.gov/pubmed/31034184Summary: In a double-blind, randomized, phase 3 trial, 135 overweight and obese adolescents, aged 10 to 17 years with T2DM, were randomly assigned to receive subcutaneous liraglutide (up to 1.8 mg per day) or placebo, bot...